![Peter M. Elias](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peter M. Elias
Chief Tech/Sci/R&D Officer at Ceragenix Corp.
Peter M. Elias active positions
Companies | Position | Start | End |
---|---|---|---|
Ceragenix Corp. | Chief Tech/Sci/R&D Officer | 01/05/2004 | - |
Career history of Peter M. Elias
Former positions of Peter M. Elias
Companies | Position | Start | End |
---|---|---|---|
OnSource Corp. | Chief Tech/Sci/R&D Officer | - | 27/06/2005 |
Ceragenix Pharmaceuticals, Inc.
![]() Ceragenix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ceragenix Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on infectious disease and dermatology. It offers two base technologies: Ceragenins and Barrier Repair. The Ceragenins is used for the treatment of infectious disease and Barrier Repair Technology is used for the treatment of dermatological disorders, including atopic dermatitis, neonatal skin disorders and others. The company was founded in 2002 and is headquartered in Denver, CO. | Chief Tech/Sci/R&D Officer | 01/05/2005 | - |
Training of Peter M. Elias
Stanford University | Undergraduate Degree |
The University of California, San Francisco | Doctorate Degree |
Statistics
International
United States | 6 |
Operational
Chief Tech/Sci/R&D Officer | 3 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sectoral
Consumer Services | 4 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 3 |
---|---|
OnSource Corp. | Consumer Services |
Ceragenix Pharmaceuticals, Inc.
![]() Ceragenix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ceragenix Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on infectious disease and dermatology. It offers two base technologies: Ceragenins and Barrier Repair. The Ceragenins is used for the treatment of infectious disease and Barrier Repair Technology is used for the treatment of dermatological disorders, including atopic dermatitis, neonatal skin disorders and others. The company was founded in 2002 and is headquartered in Denver, CO. | Health Technology |
Ceragenix Corp. |
- Stock Market
- Insiders
- Peter M. Elias
- Experience